Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the field randomised trial
Russell Scott, Mark Donoghoe, Gerald F Watts, Richard O'Brien, Christopher Pardy, Marja-Riitta Taskinen, Timothy ME Davis, Peter G Colman, Patrick Manning, Gregory Fulcher, Anthony C Keech
Cardiovascular Diabetology | BMC | Published : 2011
The FIELD study was supported by a grant from Laboratoires Fournier SA, Dijon, France (now part of Abbott) and the National Health and Medical Research Council (NHMRC) of Australia, and was coordinated independently by the NHMRC Clinical Trials Centre, University of Sydney. The authors thank Rhana Pike from the NHMRC Clinical Trials Centre, for assistance with the manuscript.